This market research report on US companion animal diagnostics market offers analysis on market size & forecast, market share, industry trends, growth drivers, and vendor analysis. The market study also includes insights on segmentation by product (diagnostic analyzers & imaging equipment, consumables, & software), by animal type (dog & cat), by technology (diagnostic imaging, clinical chemistry, hematology, immunodiagnostics, microbiology & histopathology, & molecular diagnostics), and by end-users (veterinary reference laboratories, veterinary hospitals & clinics, and others).
US Companion Animal Diagnostics Market - Overview
The significant rise in ownership of pets due to an exponential increase in disposable income and modern lifestyles is propelling the growth of the US companion animal diagnostics market. The high percentage of urban population and separation from farm animals and nature is stimulating Americans to bring cats and dogs as domestic companions in their homes. Pet owners are becoming extra cautious about the health of their pets, which in turn, is leading to an increase in regular diagnostic check-ups and situational check-ups in the US market. The rising awareness among the owners about the availability of various diagnostic tests for diagnosis and treatment of diseases in cats and dogs is expected to increase in the US market over the next few years. The top companies are investing in technological advancements to meet the growing requirement for innovative animal diagnostic tools and platforms in the US market. The focus on the development of cost-effective, flexible treatment tools capable of delivering faster and accurate results will boost revenues in the market. The growing number of pet adoption among millennials, increasing pet healthcare expenditure, higher concentration of key players, and a high number of homes with pets are some of the major factors attributing to the growth of the US market. Obesity, dental diseases, arthritis, allergies, ear infections, skin infections, kidney diseases, bladder or UTIs, thyroid disorders, and diabetes are some of the most common ailments in the US companion animal diagnostics market.
The consumers are signing up for regular diagnosis and glucose monitoring that help them identify the disease at an early stage and begin appropriate therapy to reduce the risk of diabetic complications in their pets in the US market. The advent of miniaturization, microfluidics, and usage of software platforms supported the development and commercialization of in-vitro diagnostics devices, imaging systems, and point-of-care diagnostics will transform the market. The US companion animal diagnostics market is estimated to reach values of more than $2.5 billion by 2023, growing at a CAGR approximately 7% during 2017-2023.
US Companion Animal Diagnostics Market - Dynamics
The rising number of new product approvals and launches is driving the demand in the US companion animal diagnostics market. Leading vendors are strategically developing commercial launches of their animal diagnostic devices and consumables or reagents for diagnosing various acute and chronic diseases in cats and dogs. The increasing investments in R&D activities will propel market growth and demand over the next few years. Multiple players are actively involved in launching innovative devices to penetrate and tap the enormous growth potential prevailing in the market. For instance, leading players such as IDEXX Laboratories and Abaxis are gaining a significant presence in the market owing to their continuous involvement in new product innovations and launches. The launch of a broad range of innovative and highly advanced products will boost revenues in the US companion animal diagnostics market. Companies such as Heska, OR Technology, and Rayence are also engaged in developing new products and are focusing to gain regulatory approvals for their products in the US market.
US Companion Animal Diagnostics Market - Segmentation
This market research report includes a detailed segmentation of the market by product, animal type, technology, and end-users.
US Companion Animal Diagnostics Market – By Product
Availability of various reagents and test kits will boost the demand for consumables in the US companion animal diagnostics market
The US companion animal diagnostics market by product is segmented into diagnostic analyzers & imaging equipment, consumables, & software. Consumables segment dominated more than half of the market share in 2017, growing at a CAGR of over 8% during the forecast period. The extensive use of a wide array of various reagents and test kits for performing multiple diagnostic tests, catering to different requirements of veterinarians is propelling the growth of this segment in the US market. The consumables segment predominantly include substrates, enzymes, electrolytes, specific proteins, lipids, and other test kits, which are useful to obtain accurate results in diagnostic procedures. The growing demand for in-clinic diagnostic procedures across veterinary diagnostic labs in the US market will create lucrative opportunities for players operating in this region. The top companies are offering consumables such as reagents, assays, and biomarkers to gain a larger US companion animal diagnostics market share. The growing preference for automated analyzers and advanced imaging equipment in reference laboratories and other veterinary practices will boost the demand for diagnostic analyzers and imaging equipment in the global market. Moreover, the useof software for integration of various diagnostic platforms will increase the efficiency of veterinarians’ workflow in the US market.
US Companion Animal Diagnostics Market – By Animal Type
Prevalence of various chronic diseases in dogs to drive the US companion animal diagnostics market during the forecast period
The animal type segment in the US companion animal diagnostics marketis classified into dogs and cats. Dogs occupied close to 2/3rd of the total market share in 2017, growing at a CAGR of around 7% during the forecast period. Thegrowing prevalence and incidence of various acute and chronic diseases in dogsare contributing to the growth of this segment in the US market. The rising awareness of the need for collaboration between the fields of veterinary and human medicine on preventing the spread of diseases from companion animals into humans will boost demand for innovative products in the US market. Blood tests, heartworm tests, fecal tests, urinalysis, and radiography are some of the essential diagnostic tests to be performed in dogs for analyzing body condition and diagnosing various diseases in the US. The development of highly advanced and automated hematology analyzers will contribute to the growth of this segment in the US companion animal diagnostics market. The growing number of US households with pet ownership and an increase in expenditure on pet care products will propel the growth of the cat segment in the US market. The rising incidences of obesity, dental diseases, arthritis, allergies, ear infections, skin infections, kidney diseases, bladder, UTIs, thyroid disorders, and diabetes is contributing to the demand in this segment in the US.
US Companion Animal Diagnostics Market – By Technology
The launch of innovative imaging systems to contribute to the revenues in the US companion animal diagnostics market
The US companion animal diagnostics market by technology is categorized into diagnostic imaging, clinical chemistry, hematology, immunodiagnostics, microbiology & histopathology, & molecular diagnostics. Diagnostic imaging dominated more than 1/3rd of the total market share in 2017, growing at a CAGR of around 8% during the forecast period. The increasing technological innovations and their accuracy in diagnosing specific diseases in cats and dogsareprimarily driving the growth of this segment in the US market. Top companies such as Esaote, Agfa-Gevaert Group, Carestream Health, Hallmarq Veterinary Imaging, GE Healthcare, Shenzhen Mindray Bio-Medical Electronics, and FUJIFILM are offering a diverse range of imaging systems to suit various requirements and needs of end-users in the US market. The launch of radiography systems that are optimized with advanced features including customized animal-image processing, a full suite of veterinary measurement tools, and vet-specific order entry and exam views will revolutionize the US companion animal diagnostics market. Players are launching portable, reliable, and cost-effective analyzer making urinalysis chemistry testing easier and more reproducible in the clinical chemistry segment in the US market.
US Companion Animal Diagnostics Market – By End-User
Rising awareness about zoonotic and pet-related diseases to contribute to the demand for veterinary reference laboratory in the US companion animal diagnostics market
The end-user segment in the US companion animal diagnostics marketis divided into veterinary reference laboratories, veterinary hospitals & clinics, and others (veterinary academic and research institutes and pet owners). The veterinary reference laboratories occupied more than half of the total market share in 2017, growing at a CAGR of around 6% during the forecast period. The increasing pet adoption and expenditure on pet care, increasing demand for pet insurance, increasing number of veterinary practitioners and their growing income levels, and risingawareness about zoonotic and pet-related diseasesare some of the major factors attributing to the growth of this segment in the US market. The market is expected to benefit from the increase in the volume of hematology, immunodiagnostics, and clinical chemistry tests by veterinarians as they are widely used for diagnosing a broad range of diseases and ailments. The increase in the volume of diagnostic testing in these laboratories will attribute to the revenues in the US companion animal diagnostics market. The availability of better healthcare infrastructure for animals in hospitals and clinics will propel the development of the US market.
Key Vendor Analysis
The US companion animal diagnostics marketcharacterized by the presence of several global, regional, and local players offering a diverse array of diagnostic analyzers, imaging equipment, and consumables. The top vendors are developing innovative products and expanding their product portfolios to sustain the competition levels in the market. Leading companies are adopting new technologies to improve their market presence in the US region. Several players are partnering with pet care companies and government organization to gain traction among pet owners in the US companion animal diagnostics market. Also, vendors are focusing on developing and commercializing innovative animal diagnostics systems to gain a competitive advantage in the US market.
The major vendors in the US companion animal diagnostics market are:
- Carestream Health
- IDEXX Laboratories
Other prominent vendors in the US companion animal diagnostics market areAccuplex Diagnostics, Agfa-Gevaert NV, Alvedia, Aquila Diagnostics Systems, BioMérieux, Boule Diagnostics, CLINDIAG SYSTEMS, Diagnostic Imaging Systems, Erba Diagnostics, Hallmarq Veterinary Imaging, HyTest Ltd., IDvet, Petnostics, Randox Laboratories, Rayence Inc, ScheBo Biotech, Siemens Healthcare, Shenzhen Mindray Bio-Medical Electronics, Thermo Fisher Scientific, Woodley Equipment Company, and Zoologix.
Key market insights include
- The analysis of US companion animal diagnostics market provides market size and growth rate for the forecast period 2018-2023.
- It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about theUS companion animal diagnostics market.
- The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
- It offers a complete overview of market segments and the regional outlook ofUS companion animal diagnostics market.
- The report offers a detailed overview of the vendor landscape, competitive analysis, and key market strategies to gain competitive advantage.
FILL IN YOUR DETAILS BELOW TO GET FREE SAMPLE OF THIS REPORT
Our reports have been used by over 10K customers, including:
CEO, Co-founder Audink Inc., DBA Audios
The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow.
Senior Product Manager Interstates
I recently purchased a key Arizton Industry Outlook & Forecast in order to better understand growth for specific market segments and the macro environmental factors impacting this growth. I found Arizton’s coverage of the market dynamics and key takeaways to be insightful and valuable. The segmentation breakouts gave me the information I needed to guide strategic considerations.
Manager Market Analyst Power
Generation & Energy Rolls-Royce Power Systems AG
The provided information by Arizton really met my expectations. Especially the deep information about the datacenter ecosystem was very helpful. Furthermore, I absolutely appreciate the optimal service from the key account managers of Arizton. It was always a pleasure working with them.